CIK 0001425205
- Accelerated filer
IOVANCE BIOTHERAPEUTICS, INC.
Sign in to watch- Ticker
- IOVA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 753254381
- Phone
- +1 650-260-7120
- Business address
- 825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
- Former names
- Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 99 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-08 | Countouriotis Athena Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2020-06-01 | Fardis Maria President and CEO | Shares withheld for taxes | −1,894 | $33.12 | $63K | 298,786 |
| 2020-05-01 | Fardis Maria President and CEO | Shares withheld for taxes | −1,894 | $32.00 | $61K | 300,680 |
| 2020-04-01 | Fardis Maria President and CEO | Shares withheld for taxes | −1,494 | $27.94 | $42K | 302,574 |
| 2020-03-02 | Fardis Maria President and CEO | Shares withheld for taxes | −1,321 | $35.99 | $48K | 304,068 |
| 2020-02-03 | Fardis Maria President and CEO | Shares withheld for taxes | −1,302 | $22.54 | $29K | 305,389 |
Page 23 of 23 · 446 trades